FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women
October 20, 2026
October 20, 2026
WASHINGTON, Oct. 20 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following news release:
* * *
FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women
*
The U.S. Food and Drug Administration yesterday approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus app . . .
* * *
FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women
*
The U.S. Food and Drug Administration yesterday approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus app . . .